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Abstract
The three-event stack cotton GHB614 9 LLCotton25 9 MON 15985 was produced by conventional
crossing to combine three single cotton events, GHB614, LLCotton25 and MON 15985. The EFSA GMO
Panel previously assessed the three single events and did not identify safety concerns. No new data
on the single events that could lead to modiﬁcation of the original conclusions on their safety were
identiﬁed. Based on the molecular, agronomic, phenotypic and compositional characteristics,
the combination of the single events and of the newly expressed proteins in the three-event stack
cotton did not give rise to food and feed safety or nutritional issues. Food and feed derived from
cotton GHB614 9 LLCotton25 9 MON 15985 are expected to have the same nutritional impact as
those derived from the non-GM comparator. In the case of accidental release of viable
GHB614 9 LLCotton25 9 MON 15985 cottonseeds into the environment, this three-event stack cotton
would not raise environmental safety concerns. The post-market environmental monitoring plan and
reporting intervals are in line with the intended uses of cotton GHB614 9 LLCotton25 9 MON 15985.
In conclusion, the GMO Panel considers that cotton GHB614 9 LLCotton25 9 MON 15985, as
described in this application, is as safe as the non-GM comparator with respect to potential effects on
human and animal health and the environment.
© 2018 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf
of European Food Safety Authority.
Keywords: GMO, cotton GHB614 9 LLCotton25 9 MON 15985, Regulation (EC) 1829/2003, Cry1Ac,
Cry2Ab2, GUS, NPTII, 2mEPSPS, PAT
Requestor: Competent Authority of the Netherlands
Question number: EFSA-Q-2011-00134
Correspondence: GMO@efsa.europa.eu
EFSA Journal 2018;16(4):5213www.efsa.europa.eu/efsajournal
Panel members: Andrew Nicholas Birch, Josep Casacuberta, Adinda De Schrijver, Mikołaj Antoni
Gralak, Philippe Guerche, Huw Jones, Barbara Manachini, Antoine Messean, Hanspeter Naegeli, Elsa
Ebbesen Nielsen, Fabien Nogue, Christophe Robaglia, Nils Rostoks, Jeremy Sweet, Christoph Tebbe,
Francesco Visioli and Jean-Michel Wal.
Acknowledgements: The Panel wishes to thank the members of its standing Working Groups on
Molecular Characterisation, Food/Feed and Environmental Risk Assessment for the preparatory work on
this scientiﬁc output, and EFSA staff members Michele Ardizzone and Jose Angel Gomez Ruiz for the
support provided to this scientiﬁc output.
Suggested citation: EFSA GMO Panel (EFSA Panel on Genetically Modiﬁed Organisms), Naegeli H,
Birch AN, Casacuberta J, De Schrijver A, Gralak MA, Guerche P, Jones H, Manachini B, Messean A,
Nielsen EE, Nogue F, Robaglia C, Rostoks N, Sweet J, Tebbe C, Visioli F, Wal J-M, Broll H, Gennaro A,
Neri FM and Paraskevopoulos K, 2018. Scientiﬁc Opinion on the assessment of genetically modiﬁed
cotton GHB614 9 LLCotton25 9 MON 15985 for food and feed uses, under Regulation (EC) No 1829/
2003 (application EFSA-GMO-NL-2011-94). EFSA Journal 2018;16(4):5213, 27 pp. https://doi.org/10.
2903/j.efsa.2018.5213
ISSN: 1831-4732
© 2018 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf
of European Food Safety Authority.
This is an open access article under the terms of the Creative Commons Attribution-NoDerivs License,
which permits use and distribution in any medium, provided the original work is properly cited and no
modiﬁcations or adaptations are made.
The EFSA Journal is a publication of the European Food
Safety Authority, an agency of the European Union.
Assessment of GM cotton GHB614 3 LLCotton25 3 MON 15985
www.efsa.europa.eu/efsajournal 2 EFSA Journal 2018;16(4):5213
Summary
Following the submission of an application (EFSA-GMO-NL-2011-94) under Regulation (EC) No 1829/
2003 from Bayer CropScience AG, the Panel on Genetically Modiﬁed Organisms of the European Food
Safety Authority (GMO Panel) was asked to deliver a scientiﬁc opinion on the safety of insect-resistant
and herbicide-tolerant genetically modiﬁed (GM) cotton GHB614 9 LLCotton25 9 MON 15985
(Unique Identiﬁer BCS-GHØØ2-5 9 ACS-GHØØ1-3 9 MON-15985-7). The scope of the application
EFSA-GMO-NL-2011-94 is for import, processing, and food and feed uses of cotton
GHB614 9 LLCotton25 9 MON 15985 within the European Union (EU) but excludes cultivation in the EU.
In delivering its scientiﬁc opinion, the GMO Panel considered the data available on the single
events, the information presented in application EFSA-GMO-NL-2011-94, additional information
provided by the applicant, the scientiﬁc comments submitted by the Member States and relevant
scientiﬁc publications. The three-event stack cotton GHB614 9 LLCotton25 9 MON 15985 was
produced by conventional crossing to combine three single cotton events: GHB614, expressing the
2mEPSPS protein for tolerance to glyphosate-based herbicides; LLCotton25, expressing the PAT protein
for tolerance to glufosinate-ammonium-based herbicides; and MON 15985, expressing the Cry1Ac and
Cry2Ab2 proteins which confer resistance to certain lepidopteran pest and the NPTII and GUS proteins
which were used as selectable markers.
The GMO Panel evaluated cotton GHB614 9 LLCotton25 9 MON 15985 with reference to the scope
and appropriate principles described in its guidelines for the risk assessment of GM plants and derived
food and feed, the environmental risk assessment of GM plants and the post-market environmental
monitoring of GM plants. The GMO Panel Guidance Documents establish the principle that where all
single events have been assessed, the risk assessment of stacked events should focus mainly on issues
related to (a) stability of the inserts, (b) expression of the introduced genes and their products and (c)
potential synergistic or antagonistic effects resulting from the combination of the events.
For application EFSA-GMO-NL-2011-94, the previous assessment of the three single events
(GHB614, LLCotton25 and MON 15985) provided the basis to evaluate the three-event stack cotton.
Cotton GHB614, LLCotton25 and MON 15985 were previously assessed by the GMO Panel and no
safety concerns were identiﬁed. No safety issue was identiﬁed by updated bioinformatics analyses nor
reported by the applicant for any the three single cotton events since the publication of the respective
scientiﬁc opinions. Consequently, the GMO Panel considers that its previous conclusions on the safety
of the single cotton events remain valid.
The risk assessment of the three-event stack cotton included the molecular characterisation of the
inserted DNA and analysis of protein expression. An evaluation of the comparative analysis of
compositional and agronomic/phenotypic characteristics was undertaken, and the safety of the newly
expressed proteins and the whole food/feed was evaluated with respect to nutritional characteristics
and potential toxicity and allergenicity. An evaluation of environmental impacts and post-market
environmental monitoring plans was also carried out.
The molecular data establish that the events stacked in cotton GHB614 9 LLCotton25 9 MON 15985
have retained their integrity. Protein expression analyses showed that the levels of the newly expressed
proteins are similar in the three-event stack and the single events. No indications of interactions that may
affect the integrity of the events and the levels of the newly expressed proteins in this three-event stack
cotton were identiﬁed.
The comparative analysis of cottonseed composition and agronomic/phenotypic characteristics
identiﬁed no differences between cotton GHB614 9 LLCotton25 9 MON 15985 and the non-GM
comparator that required further assessment for food/feed safety or environmental impact, except for
increased levels of gossypol, dihydrosterculic acid and a-tocopherol in GM cottonseed.
Based on the molecular, agronomic, phenotypic and compositional characteristics, the combination
of cotton events GHB614, LLCotton25 and 9 MON 15985 in the three-event stack cotton did not give
rise to issues regarding food and feed safety and nutrition. The combination of the newly expressed
proteins in the three-event stack cotton did not raise concerns for human and animal health. The
toxicological and nutritional assessment identiﬁed no concern related to the increased levels of
gossypol, dihydrosterculic acid and a-tocopherol. The nutritional impact of food and feed derived from
cotton GHB614 9 LLCotton25 9 MON 15985 is not expected to differ from that of food and feed
derived from the non-GM comparator.
Considering the combined events, the outcome of the comparative analysis, the routes of exposure
and limited exposure levels, the GMO Panel concludes that this three-event stack cotton would not
raise safety concerns in the case of accidental release of viable GM cottonseeds into the environment.
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In conclusion, the GMO Panel considers that the information available for cotton
GHB614 9 LLCotton25 9 MON 15985 addresses the scientiﬁc comments raised by Member States and
that cotton GHB614 9 LLCotton25 9 MON 15985, as described in this application, is as safe as the
non-GM comparator with respect to potential effects on human and animal health and the
environment in the context of the scope of this application.
Given that no safety concerns were identiﬁed on food/feed derived from cotton GHB614 9
LLCotton25 9 MON 15985, the GMO Panel considers that post-market monitoring of these products is
not necessary. The post-market environmental monitoring plan and reporting intervals are in line with
the intended uses of cotton GHB614 9 LLCotton25 9 MON 15985.
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1. Introduction
1.1. Background
On 18 February 2011, the European Food Safety Authority (EFSA) received from the Competent
Authority of the Netherlands application EFSA-GMO-NL-2011-94, for authorisation of genetically
modiﬁed (GM) cotton GHB614 9 LLCotton25 9 MON 15985 for food and feed uses, import and
processing submitted by Bayer CropScience AG within the framework of Regulation (EC) No 1829/2003
on genetically modiﬁed food and feed.1,2
After receiving the application EFSA-GMO-NL-2011-94 and in accordance with Articles 5(2)(b) and 17
(2)(b) of the Regulation (EC) No 1829/2003, EFSA informed the Member States and the European
Commission, and made the summary of the application publicly available on the EFSA website.3 EFSA
initiated a formal review of the application to check compliance with the requirements laid down in
Articles 5(3) and 17(3) of the Regulation (EC) No 1829/2003. On 16 June 2015, EFSA received additional
information requested under the completeness check (requested on 20 April 2011). On 15 July 2015,
EFSA declared the application as valid in accordance with Articles 6(1) and 18(1) of Regulation (EC)
No 1829/2003.
EFSA made the valid application available to the Member States and the European Commission, and
consulted nominated risk assessment bodies of Member States, including national Competent
Authorities within the meaning of Directive 2001/18/EC4 following the requirements of Articles 6(4)
and 18(4) of Regulation (EC) No 1829/2003, to request their scientiﬁc opinion. Member State had
three months after the opening of the Member State commenting period (until 4 July 2016) to make
their opinion known.
The GMO Panel carried out a scientiﬁc risk assessment of the GM cotton GHB614 9
LLCotton25 9 MON 15985. On 24 July 2015, 7 April 2016, 12 May 2016, 29 September 2016 and 17
November 2017, the GMO Panel requested additional information from the applicant. The applicant
provided the requested information on 22 October 2015, 6 July 2016, 16 August, 3 November 2017
and 2 February 2018, respectively. On 20 February 2018, the applicant provided supplementary
information spontaneously. After receipt and assessment of the full data package, the GMO
Panel ﬁnalised its risk assessment of cotton GHB614 9 LLCotton25 9 MON 15985.
In giving its scientiﬁc opinion to the European Commission, the Member States and the applicant,
and in accordance with Articles 6(1) and 18(1) of Regulation (EC) No 1829/2003, EFSA has
endeavoured to respect a time limit of 6 months from the acknowledgement of the valid application.
As additional information was requested by the GMO Panel, the time limit of 6 months was
extended accordingly, in line with Articles 6(1), 6(2), 18(1), and 18(2) of Regulation (EC)
No 1829/2003.
According to Regulation (EC) No 1829/2003, this scientiﬁc opinion is to be seen as the report
requested under Articles 6(6) and 18(6) of that Regulation and thus will be part of the EFSA overall
opinion in accordance with Articles 6(5) and 18(5).
1.2. Terms of Reference as provided by the requestor
The GMO Panel was requested to carry out a scientiﬁc assessment of cotton GHB614 9
LLCotton25 9 MON 15985 (Gossypium hirsutum) for food and feed uses, import and processing in
accordance with Articles 6(6) and 18(6) of Regulation (EC) No 1829/2003.
Where applicable, any conditions or restrictions which should be imposed on the placing on the
market and/or speciﬁc conditions or restrictions for use and handling, including post-market monitoring
requirements based on the outcome of the risk assessment and, in the case of GMOs or food/feed
containing or consisting of GMOs, conditions for the protection of particular ecosystems/environments
and/or geographical areas should be indicated in accordance with Articles 6(5)(e) and 18(5)(e) of
Regulation (EC) No 1829/2003.
1 Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 September 2003 on genetically modiﬁed
food and feed. OJ L 268, 18.10.2003, p. 1–23.
2 The original submission also included the two-event stack cotton LLCotton25 9 MON15985. However, the two-event stack was
subsequently removed by the applicant and is not included in the scope of this application.
3 Available online: http://registerofquestions.efsa.europa.eu/roqFrontend/questionLoader?question=EFSA-Q-2011-00134
4 Directive 2001/18/EC of the European Parliament and of the Council of 12 March 2001 on the deliberate release into the
environment of genetically modiﬁed organisms and repealing Council Directive 90/220/EEC. OJ L 106, 12.3.2001, p. 1–38.
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The GMO Panel was not requested to give an opinion on the information required under Annex II
to the Cartagena Protocol. Furthermore, the GMO Panel did not consider proposals for labelling and
methods of detection (including sampling and the identiﬁcation of the speciﬁc transformation event in
the food/feed and/or food/feed produced from it), which are matters related to risk management.
2. Data and methodologies
2.1. Data
In delivering its scientiﬁc opinion, the GMO Panel took into account application EFSA-GMO-NL-2011-94,
additional information provided by the applicant, scientiﬁc comments submitted by the Member States
and relevant scientiﬁc publications.
2.2. Methodologies
The GMO Panel carried out a scientiﬁc risk assessment of cotton GHB614 9 LLCotton25 9
MON 15985 for food and feed uses, in accordance with Articles 6(6) and 18(6) of Regulation (EC)
No 1829/2003. The GMO Panel took into account the appropriate principles described in its guidelines for
the risk assessment of GM plants and derived food and feed (EFSA, 2006a, 2007; EFSA GMO Panel,
2011a), the environmental risk assessment (ERA) of GM plants (EFSA GMO Panel, 2010), and the post-
market environmental monitoring (PMEM) of GM plants (EFSA GMO Panel, 2011b).
The EFSA guidance applicable to this application establishes that ‘Where all single events have been
assessed, the risk assessment of stacked events should focus mainly on issues related to (a) stability,
(b) expression of the events and (c) potential interactions between the events’ (EFSA, 2006a, 2007).
Additional information received after May 2011 was assessed in accordance with 2011 guidance (EFSA
GMO Panel, 2011a).
The comments raised by Member States are addressed in Annex G of EFSA’s overall opinion and
were taken into consideration during the scientiﬁc risk assessment.
3. Assessment
3.1. Introduction
Cotton GHB614 9 LLCotton25 9 MON 15985 was developed by conventional crossing of single
lines GHB614 (expressing 2mEPSPS protein), LLCotton25 (expressing PAT protein) and MON 15985
(expressing Cry1Ac, Cry2Ab2, NPTII and GUS proteins) to confer resistance to certain lepidopteran
pests and tolerance to glyphosate- and glufosinate-ammonium-based herbicides. Resistance to certain
lepidopteran pests, such as the cotton bollworm larvae (Helicoverpa zea), tobacco budworm larvae
(Heliothis virescens), pink bollworm (Pectinophora gossypiella) and beet armyworm larvae
(Spodoptera exigua), is provided by the expression of the Cry1Ac and Cry2Ab2 proteins, which have
an insecticidal effect on larvae of certain lepidopteran species. Tolerance to glyphosate is achieved by
the expression of the 2mepsps gene (modiﬁed 5-enolpyruvylshikimate 3-phosphate synthase gene),
and tolerance to glufosinate-ammonium-based herbicides is achieved by the expression of
phosphinothricin acetyltranferase (PAT), an enzyme that acetylates L-glufosinate ammonium.
All three single events were assessed previously (see Table 1) and no concerns for human and
animal health or environmental safety were identiﬁed.
3.2. Updated information on single events
Since the publication of the scientiﬁc opinions on the single cotton events (see Table 1), no safety
issue pertaining to any of the three single events has been reported by the applicant.
Table 1: Single cotton events already assessed by the GMO Panel
Event Application EFSA Scientiﬁc Opinion
GHB614 EFSA-GMO-NL-2008-51 EFSA (2009a)
LLCotton25 EFSA-GMO-NL-2005-13 EFSA (2006b)
MON 15985 EFSA-GMO-UK-2008-57
EFSA-GMO-RX-MON15985
EFSA GMO Panel (2014a)
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Updated bioinformatic analyses for events GHB614, LLCotton255 and MON 15985 conﬁrmed that no
known endogenous genes were disrupted by any of the inserts.6
Updated bioinformatic analyses of the amino acid sequence of the newly expressed Cry1Ac,
Cry2Ab2, 2mEPSPS, NPTII, GUS and PAT proteins conﬁrmed previous results indicating no signiﬁcant
similarities to known toxins and allergens.6,7 Updated bioinformatics analyses of the newly created
open reading frames (ORFs) within the inserts, or spanning the junctions between the inserts to
identify ORFs with signiﬁcant similarity to toxins or allergens not previously assessed, revealed that for
event MON 15985 a single ORF exceeded the allergenicity assessment threshold of 35% identity using
an 80 amino acid sliding window approach. This ORF is found within the transcriptional unit of the
Cry2Ab2 coding sequence driven by the cauliﬂower mosaic virus 35S promoter, but it is in a different
reading frame to the Cry2Ab2 ORF and does not contain any in-frame translational start codons (ATG).
In conclusion, these analyses indicated that the expression of an ORF showing signiﬁcant similarities to
toxins or allergens for any of the events in cotton GHB614 9 LLCotton25 9 MON 15985 is highly
unlikely.6,7,8
In order to assess the possibility for horizontal gene transfer (HGT) by homologous recombination
(HR), the applicant performed a sequence identity analysis for events GHB614, LLCotton25 and
MON 15985 to microbial DNA.6 The likelihood and potential consequences of plant-to-bacteria gene
transfer are described in Section 3.6.
Based on the above information, the GMO Panel considers that its previous conclusions on the
safety of the single cotton events remain valid.
3.3. Molecular characterisation
Possible interactions that would affect the integrity of the events, the expression levels of the newly
expressed proteins or the biological function conferred by the individual inserts are considered.
3.3.1. Genetic elements and biological functions of the inserts9
Cotton events GHB614, LLCotton25 and MON 15985 were combined by conventional crossing to
produce the three-event stack cotton GHB614 9 LLCotton25 9 MON 15985. The structure of the
inserts introduced into the three-event stack cotton is described in detail in the respective EFSA
scientiﬁc opinions (Table 1) and no new genetic modiﬁcations were involved. Genetic elements in the
expression cassettes of the single events are summarised in Table 2.
Intended effects of the inserts in cotton GHB614 9 LLCotton25 9 MON 15985 are summarised in
Table 3.
Based on the known biological function of the newly expressed proteins (Table 3), the only
foreseen interactions at the biological level are between the two Cry proteins in susceptible insects.
5 The LLCotton25 event sequence used to perform the bioinformatic analyses was the sequence submitted in the original
application EFSA-GMO-NL-2005-13 but corrected for sequencing errors (http://registerofquestions.efsa.europa.eu/roqFrontend/
questionLoader?question=EFSA-Q-2017-00803).
6 Additional information: 22/10/2015 and 2/2/2018.
7 Additional information: 6/7/2016.
8 Additional information: 20/2/2018.
9 Dossier: Part I – Section C3.
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Cotton event MON 15985 also contains a gene coding for an aminoglycoside adenylyltransferase
(AAD) enzyme, which confers resistance to spectinomycin and streptomycin. This gene was only used
as a selectable marker during the development of MON 15985. This gene is under the control of a
prokaryotic promoter and it is therefore not expressed in parental line cotton MON 15985 (EFSA GMO
Panel, 2011c, 2014a).
Table 2: Genetic elements in the expression cassettes of the events stacked in cotton
GHB614 9 LLCotton25 9 MON 15985
Event Promoter 5’ UTR Transit peptide Coding region Terminator
GHB614 Ph4a748At
(Arabidopsis
thaliana)*
– TPotpC (Zea mays
and Helianthus
annuus)
2mepsps
(Z. mays)
3’histon At
(A. thaliana)
LLCotton25 P35S3
(CaMV)
– No bar (Streptomyces
hygroscopicus)
3’ nos
(Agrobacterium
tumefaciens)
MON 15985 e35S
(CaMV)
– No cry1Ac (Bacillus
thuringiensis)
7S 3’
(Glycine max)
35S
(CaMV)
– No nptII (Tn7) 3’ nos
(A. tumefaciens)
e35S
(CaMV)
– No uidA
(Escherichia coli)
3’ nos
(A. tumefaciens)
e35S
(CaMV)
hsp70
(Petunia)
CTP2
(A. thaliana)
cry2Ab2
(B. thuringiensis)
3’ nos
(A. tumefaciens)
UTR: untranslated region; CaMV: cauliﬂower mosaic virus.
*: Source of genetic material.
Table 3: Characteristics and intended effects of the events stacked in cotton
GHB614 9 LLCotton25 9 MON 15985
Event Protein
Donor organism and biological
function
Intended effects in GM plant
GHB614 2mEPSPS Based on a gene from Zea mays.
5-enolpyruvylshikimate-3-phosphate
synthase (EPSPS) is an enzyme involved
in the shikimic acid pathway for aromatic
amino acid biosynthesis in plants and
microorganisms (Lebrun et al., 2003)
The amino acid sequence of the maize EPSPS
enzyme was modiﬁed by two substitutions to
render it tolerant to glyphosate. Expression of
2mEPSPS confers tolerance to glyphosate-
based herbicides
LLCotton25 PAT Based on a gene from Streptomyces
hygroscopicus. Encoded by the bar gene,
phosphinothricin-acetyl-transferase (PAT)
confers resistance to the antibiotic
bialaphos (Thompson et al., 1987)
The bar gene inserted in cotton LLcotton25
differs from the native by two N-terminal
codons. Expression of PAT in cotton
LLCotton25 confers tolerance to glufosinate-
ammonium-based herbicides
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3.3.2. Integrity of the events in the three-event stack10
The genetic stability of the inserted DNA over multiple generations in the single cotton events
GHB614, LLCotton25 and MON 15985 was demonstrated previously (see Table 1). Integrity of these
events in cotton GHB614 9 LLCotton25 9 MON 15985 was demonstrated by Southern analyses.
3.3.3. Information on the expression of the inserts7,11
Cry1Ac, Cry2Ab2, 2mEPSPS, PAT, NPTII and GUS protein levels were analysed by enzyme-linked
immunosorbent assay (ELISA) in material harvested from replicated ﬁeld trials at three locations in the
USA in 2014. Samples analysed included leaf (4–6 leaf, square initiation and 2 weeks after ﬂowering),
root (square initiation), pollen (ﬂowering) and fuzzy seed (maturity) both those treated and not
treated with glyphosate and glufosinate. Since cottonseeds are the main raw commodities used for
food and feed purposes, protein levels in cottonseeds from GHB614 9 LLCotton25 9 MON 15985 (the
highest mean values, regardless the treatment) are summarised in Table 4.
Event Protein
Donor organism and biological
function
Intended effects in GM plant
MON 15985 Cry1Ac
AAD
NPTII
GUS
Cry2Ab2
Based on genes from Bacillus
thuringiensis subsp. kurstaki HD-73.
B. thuringiensis is an insect pathogen; its
insecticidal activity is attributed to the
expression of crystal protein (cry) genes
(Donovan et al., 1992)
Bacterial gene comprising its own
regulatory elements and coding for an
aminoglycoside-modifying enzyme, 3’(9)-
O-nucleotidyltransferase from the
transposon Tn7 under a prokaryotic
promoter (Flung et al., 1985)
Based on a gene from bacterial
transposon Tn5. Neomycin
phosphotransferase II (NPTII) inactivates
by phosphorylation a range of
antibiotics, including kanamycin and
neomycin (Fraley et al., 1983; EFSA,
2009b)
Based on a gene from Escherichia coli
strain K12. Encoded by the uidA gene, b-
D-glucuronidase (GUS) catalyses the
hydrolysis of a range of b-glucuronides
(Gilissen et al., 1998)
Based on genes from B. thuringiensis
subsp. kurstaki. B. thuringiensis is an
insect pathogen; its insecticidal activity is
attributed to the expression of crystal
protein (cry) genes (Widner and
Whiteley, 1990)
Cotton MON 15985 expresses a synthetic
cry1Ac gene which was modiﬁed to enhance
its expression in plants. Cry1Ac is 99.4%
identical to its native (differs by 7 amino
acids). This protein is toxic to certain
lepidopteran larvae feeding on cotton
The expression of the aad gene provides
resistance to spectinomycin and streptomycin
and was used as a selectable marker for
plasmid maintenance during product
development
The nptII gene inserted in cotton MON 15985
also contains 153 bp of the gene encoding the
bleomycin binding protein. Expression of the
nptII gene allowed selection of transformed
plant cells with kanamycin in the development
of MON 531, the parental line of MON 15985
Expression of the GUS protein in cotton
MON 15985 was used as a histochemical
marker during product development
The amino acid sequence of the Cry2Ab2
protein expressed in MON 15985 is 88%
identical to the Cry2Aa protein produced by
the B. thuringiensis subsp. kurstaki. Cotton
15985 expresses the synthetic Cry2Ab2, which
is toxic to certain lepidopteran larvae feeding
on cotton
10 Dossier: Part I – Section D2; additional information: 16/8/2016 and 3/11/2017.
11 Dossier: Part I – Section D3.
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In order to assess changes in protein expression levels which may result from potential interactions
between the events, protein levels were determined for the three-event cotton stack and the
corresponding single events in different parts of the plant.
The levels of all the newly expressed proteins in the three-event cotton stack and the
corresponding singles were similar in all tissues (Appendix A). Therefore, there is no indication of an
interaction that may affect the levels of the newly expressed proteins in this stack.
3.3.4. Conclusion
The molecular data establish that the events stacked in cotton GHB614 9 LLCotton25 9
MON 15985 have retained their integrity. Protein expression analyses showed that the levels of the
newly expressed proteins are similar in the three-event stack and in the single events. Therefore, there
is no indication of an interaction that may affect the integrity of the events and the levels of the newly
expressed proteins in this stack.
Based on the known biological function of the newly expressed proteins (Table 3), the only
foreseen interactions at the biological level are between the two Cry proteins, which will be dealt with
in Sections 3.5 and 3.6.
3.4. Comparative analysis12
3.4.1. Choice of comparator and production of material for the comparative
assessment13
Application EFSA-GMO-NL-2011-94 includes data on agronomic and phenotypic characteristics
of cotton and compositional data on ginned cottonseeds (fuzzy seeds). The data were collected from
ﬁeld trials performed in the USA. The ﬁeld trials included the three-event stack cotton GHB614 9
LLCotton25 9 MON 15985, the non-GM comparator FiberMax958 (FM958) and the three single events
GHB614, LLCotton25 and MON 15985. The non-GM comparator FM958 had a similar genetic
background to the three-event stack and was considered an appropriate comparator by the GMO
Panel.
The ﬁeld trials were conducted during the 2008 growing season in seven locations in the southern-
eastern USA14 in typical cotton-growing regions.15 At each site, a randomised complete block design
was used, with three replications of the test materials. All the materials received the same (site-
speciﬁc) maintenance treatments to ensure good plant health conditions; in what follows, ‘untreated’ is
used to refer to materials treated only with conventional herbicides. The test materials were: cotton
GHB614 9 LLCotton25 9 MON 15985 (untreated), cotton GHB614 9 LLCotton25 9 MON 15985
(treated with the target herbicides16), the non-GM comparator FM958 (untreated) and the three single
Table 4: Highest mean values, standard deviation and ranges of protein levels (lg/g dry weight) in
seed (n = 15) from cotton GHB614 9 LLCotton25 9 MON 15985 treated with glyphosate
and glufosinate
Tissue/
develop-
mental
stage
Cry1Ac Cry2Ab2 2mEPSPS PAT GUS NPTII
Seed/
maturity
11.35(a)  1.13(b)
(9.92–13.22)(c)
171.21  24.03
(136.07–215.60)
105.70  12.79
(81.48–127.63)
161.02  19.35
(122.48–193.10)
32.06  4.20
(21.77–39.52)
6.60  0.91
(5.19–8.34)
Cry: crystal protein; EPSPS: 5-enolpyruvyl-shikimate-3-phosphate synthase; PAT: phosphinothricin acetyltransferase;
GUS: b-D-glucuronidase; NPTII: neomycin phosphotransferase II.
(a): Mean.
(b): Standard deviation.
(c): Range.
12 Dossier: Part I – Section D7.1.
13 Dossier: Part I – Section D7.2.
14 Tift, GA; Jackson, AR; Crittenden, AR; Tate, MS; St. Landry, LA; Wharton, TX; and Hockle, TX.
15 Dossier: Part I – Section D7.1 (study DQ08B001).
16 The target herbicides were: a combination of glyphosate-based and glufosinate ammonium-based herbicides for the three-
event stack cotton GHB614 9 LLCotton25 9 MON 15985; glyphosate-based herbicides for the single event GHB614; and
glufosinate ammonium-based herbicides for the single event LLCotton25.
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events: GHB614 (untreated), GHB614 (treated with the target herbicides), LLCotton25 (untreated),
LLCotton25 (treated with the target herbicides) and MON 15985 (untreated).
The GMO Panel took into account the full data set provided, including the results for the three
single events. In the following sections, only the results for the three-event stack and the non-GM
comparator are discussed.
3.4.2. Agronomic and phenotypic analysis17
3.4.2.1. Agronomic and phenotypic characteristics tested under ﬁeld conditions
In total, 29 agronomic and phenotypic endpoints were measured, related to plant growth and
morphology at different life stages, reproduction, agricultural productivity, ﬁbre properties and disease
susceptibility.18
In order to test for differences between the three-event stack cotton and the non-GM comparator,
an analysis of variance (ANOVA) was applied across the ﬁeld trial sites.19
Signiﬁcant differences were observed between cotton GHB614 9 LLCotton25 9 MON 15985
(untreated) and the non-GM comparator for the following endpoints: boll type and percentage lint, all
the ﬁbre properties, number of bolls at ﬁrst position and parameters related to lepidopteran
susceptibility (Table 5).
Cotton GHB614 9 LLCotton25 9 MON 15985 (treated with the target herbicides) showed
statistically signiﬁcant differences from the non-GM comparator for the following endpoints: percentage
open bolls, boll size, micronaire, ﬁbre length uniformity, ﬁbre strength, ﬁbre elongation, number of
bolls at ﬁrst position, total number of bolls and parameters related to lepidopteran susceptibility
(Table 5).
The signiﬁcant differences are further assessed for their potential environmental impact in
Section 3.6.
Table 5: Agronomic and phenotypic endpoints for which statistically signiﬁcant differences were
observed between cotton GHB614 9 LLCotton25 9 MON 15985 (treated or not treated
with the intended herbicides) and the non-GM comparator FM958
Endpoint
Comparator
FM958
Cotton GHB614 3 LLCotton25 3
MON 15985
Untreated(a) Treated(b)
Boll type (rating 0–9) 5.5 5.7* 5.6
% open bolls 49.5 46.4 46.2*
% lint 40.5 39.2* 39.9
Boll size (g) 5.77 5.70 5.52*
Micronaire (mic units) 4.20 3.90* 3.80*
Fibre length (inches) (c) 1.19 1.17* 1.17
Fibre length uniformity (%) 85.3 84.0* 84.4*
Fibre strength (g/tex) 33.4 31.9* 31.6*
Fibre elongation (%) 4.60 4.90* 4.90*
Number of bolls at ﬁrst position (N/plant) 4.70 5.60* 5.70*
Total number of bolls (N/plant) 10.60 11.50 12.30*
Larvae in squares 2.2 0.4* 0.2*
Damaged squares 7.2 0.8* 0.3*
Larvae in ﬂowers 2.8 1.2* 1.1*
Damaged ﬂowers 3.6 1.2* 0.1*
17 Dossier: Part I – Section D7.4.
18 Agronomic parameters: plant stand, strain uniformity, lodging, number of days to ﬁrst ﬂower, number of days to ﬁrst open
boll, boll type, % open bolls, yield, % lint, no. of seeds per boll, boll size and seed index. Fibre properties: length, length
uniformity, strength, micronaire and elongation. Plant mapping: plant height, number of nodes, ﬁrst position bolls and total
number of bolls. Pest reaction: larvae in squares, damage square, larvae in ﬂowers, damaged ﬂowers, larvae in bolls and
damaged bolls.
19 A linear mixed model was used, where genotype (each combination of material and herbicide treatment) was the ﬁxed effect,
and the random effects were location, block-within-location and location-by-genotype.
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3.4.2.2. Agronomic and phenotypic characteristics tested under controlled conditions
Pollen characteristics20
Pollen germinability and viability for cotton GHB614 9 LLCotton25 9 MON 15985, the non-GM
comparator (FM958) and the three single cotton events were measured according to Barrow (1981).
The pollen was obtained from plants grown under greenhouse conditions in 2009. The applicant
observed no statistically signiﬁcant differences between cotton GHB614 9 LLCotton25 9 MON 15985,
the non-GM comparator and the single cotton events for pollen germinability and viability.
While Barrow’s test provides an indication of germination capacity, it does not measure directly pollen
germinability and viability (Barrow, 1981; Burke et al., 2004). Therefore, the data on pollen viability
supplied by the applicant in support of the comparative assessment were not considered suitable by the
GMO Panel. Given that the genetic modiﬁcation of cotton GHB614 9 LLCotton25 9 MON 15985 is not
designed to target speciﬁcally pollen germinability and viability, and that the scope of application EFSA-
GMO-NL-2011-94 excludes cultivation, the GMO Panel considers that data on pollen germinability and
viability are not required for the risk assessment of cotton GHB614 9 LLCotton25 9 MON 15985.
3.4.3. Compositional analysis21
Comparative compositional analysis was performed on fuzzy cottonseed samples obtained from
cotton GHB614 9 LLCotton25 9 MON 15985 and the non-GM comparator FM958 grown in the USA
ﬁeld trials in 2008.
Samples were analysed for 66 compositional parameters, selected in line with OECD
recommendations (OECD, 2009). Eighteen fatty acids had most of the sample values below the limit of
quantiﬁcation (LOQ) and were not analysed statistically.22 The data for the remaining 48 compounds23
were analysed with ANOVA, in order to test for differences between the three-event stack cotton and
the non-GM comparator.16
Signiﬁcant differences in fuzzy cottonseed (with maintenance management treatment only;
‘Untreated’, Table 6) were identiﬁed for 10 endpoints. Signiﬁcant differences in fuzzy cottonseed (treated
with the target herbicides; ‘Treated’, Table 6) were identiﬁed for 14 endpoints.24
Endpoint
Comparator
FM958
Cotton GHB614 3 LLCotton25 3
MON 15985
Untreated(a) Treated(b)
Larvae in bolls 1.6 0.0* 0.0*
Damaged bolls 3.4 0.2* 0.1*
The values shown are estimated means. Signiﬁcantly different entries for the GM cotton are marked with an asterisk.
(a): Cotton GHB614 9 LLCotton25 9 MON 15985 treated only with conventional herbicides.
(b): Cotton GHB614 9 LLCotton25 9 MON 15985 treated with glyphosate- and glufosinate-ammonium-based herbicides.
(c): The p-value for the untreated test material was: 0.034; the p-value for the treated material was: 0.059.
20 Dossier: Part I – Sections D4 and D7.4 (report DQ09Q003).
21 Dossier: Part I – Section D7.3.
22 The fatty acids were: caprylic (C8:0), capric (C10:0), lauric (C12:0), myristoleic (C14:1), pentadecanoic (C15:0), pentadecenoic
(C15:1), heptadecenoic (C17:1), c-linolenic (C18:3), octadecatetraenoic (C18:4), eicosenoic (C20:1), eicosadienoic (C20:2),
eicosatrienoic (C20:3), arachidonic (C20:4), eicosapentaenoic (C20:5), erucic (C22:1), docosapentaenoic (C22:5) and
docosahexaenoic (C22:6).
23 Ash, total fat, moisture, total protein, carbohydrate, acid detergent ﬁbre (ADF), neutral detergent ﬁbre (NDF), calcium, iron,
magnesium, phosphorus, potassium, zinc, aspartic acid, threonine, serine, glutamic acid, proline, glycine, alanine, cysteine,
valine, methionine, isoleucine, leucine, tyrosine, phenylalanine, histidine, lysine, arginine, tryptophan, myristic acid (C14:0),
palmitic acid (C16:0), palmitoleic acid (C16:1), stearic acid (C18:0), oleic acid (C18:1), linoleic acid (C18:2), linolenic acid
(C18:3), arachidic acid (C20:0), behenic acid (C22:0), lignoceric acid (C24:0), a-tocopherol, sterculic acid, malvalic acid,
dihydrosterculic acid, phytic acid, free gossypol and total gossypol.
24 A signiﬁcant difference between the GM cotton and the non-GM comparator was also identiﬁed for lignoceric acid (C24:0).
However, lignoceric acid (C24:0) had many analytical results below the LOQ (50 out of 126 samples) and the statistical results
for this compound were not considered by the EFSA GMO Panel.
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3.4.4. Conclusion
The GMO Panel concluded that the differences identiﬁed in the agronomic and phenotypic
characteristics between cotton GHB614 9 LLCotton25 9 MON 15985 and the non-GM comparator do
not require further assessment regarding food and feed safety. The differences are further assessed
for their potential environmental impact in Section 3.6.
The GMO Panel assessed all signiﬁcant compositional differences between cotton GHB614 9
LLCotton25 9 MON 15985 and the non-GM comparator, taking into account the potential impact on plant
metabolism and the variability reported in the OECD consensus document (OECD, 2009) and published
literature (e.g. Berberich et al., 1996). The GMO Panel did not identify any need for further food/feed
safety assessment except for gossypol, dihydrosterculic acid and a-tocopherol (see Section 3.5).
3.5. Food and feed safety assessment
3.5.1. Effect of processing25
Cotton GHB614 9 LLCotton25 9 MON 15985 will undergo existing production processes used for
conventional cotton. No novel production process is envisaged.
3.5.2. Toxicology26
3.5.2.1. Toxicological assessment of newly expressed proteins
Six proteins (PAT, 2mEPSPS, GUS, NPTII, Cry1Ac and Cry2Ab2) are newly expressed in various
tissues of cotton GHB614 9 LLCotton25 9 MON 15985. The GMO Panel has previously assessed these
proteins individually in the context of the single events (Table 2), and no safety concerns were
identiﬁed for humans and animals (Section 3.2).
Table 6: Compositional endpoints in fuzzy cottonseeds (from USA 2008 ﬁeld trials) for which
statistically signiﬁcant differences were identiﬁed between the three-event stack cotton
(treated or not treated with the intended herbicides) and the non-GM comparator
Component
Comparator
FM958
Cotton GHB614 3 LLCotton25 3 MON 15985
Untreated(a) Treated(b)
Total fat (% DM) 20.0 19.1* 19.0*
Carbohydrate (% DM) 55.1 56.1* 55.9
Calcium (% DM) 0.131 0.153* 0.155*
Phosphorus (% DM) 0.63 0.60* 0.60*
Magnesium (% DM) 0.37 0.36* 0.36*
Iron (mg/kg) 54.1 47.0* 47.5*
a-Tocopherol (mg/kg) 109.8 130.2* 134.1*
Myristic acid (C14:0) (% FA) 0.77 0.76 0.68*
Palmitoleic acid (C16:1) (% FA) 0.55 0.53 0.50*
Linoleic acid (C18:2) (% FA) 54.47 54.07 56.22*
Arachidic acid (C20:0) (% FA) 0.30 0.30 0.28*
Behenic acid (C22:0) (% FA) 0.19 0.19 0.18*
Free gossypol(c) (mg/kg DM) 5,400 6,500* 6,400*
Total gossypol (mg/kg DM) 6,000 7,200* 7,200*
Dihydrosterculic acid (% FA) 0.25 0.27* 0.26*
DM: dry matter; FA: total fatty acids.
The values shown are estimated means. Signiﬁcantly different entries for the GM cotton are marked with an asterisk.
(a): Cotton GHB614 9 LLCotton25 9 MON 15985 treated only with conventional herbicides.
(b): Cotton GHB614 9 LLCotton25 9 MON 15985 treated with glyphosate- and glufosinate-ammonium-based herbicides.
(c): The EFSA GMO Panel noted that the free gossypol content in raw cottonseeds of cotton GHB614 9 LLCotton25 9 MON 15985
and its comparator was higher than the limits set in Directive 2002/32 EC (5,000 mg/kg as fed) on undesirable substances in
feed materials.
25 Dossier: Part I – Section D7.6.
26 Dossier: Part I – Section D7.8.
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The potential for a functional interaction between the proteins newly expressed in cotton
GHB614 9 LLCotton25 9 MON 15985 was assessed with regard to human and animal health. The four
enzymatic proteins (PAT, 2mEPSPS, GUS and NPTII) catalyse distinct biochemical reactions and act on
unrelated substrates. The two insecticidal proteins (Cry1Ac and Cry2Ab2) act through cellular receptors
found in target insect species and it is reported that the gastrointestinal tract of mammals, including
humans, lacks receptors with high afﬁnity speciﬁc to Cry proteins (Hammond et al., 2013; Koch et al., 2015).
On the basis of the known biological function of the newly expressed proteins (Table 3), there is
currently no expectation for possible interactions relevant to the food and feed safety assessment of
the three-event stack cotton. Similar conclusions on possible interactions between PAT and 2mEPSPS
were drawn by the GMO Panel on the two-event stack cotton GHB614 9 LLCotton25 (EFSA-GMO-NL-
2010-77; EFSA GMO Panel, 2014b).
The GMO Panel concludes that there are no safety concerns to human and animal health related to
the newly expressed proteins PAT, 2mEPSPS, GUS, NPTII, Cry1Ac and Cry2Ab2 in cotton
GHB614 9 LLCotton25 9 MON 15985.
3.5.2.2. Toxicological assessment of components other than newly expressed proteins
This section focuses on the safety assessment of the higher levels of gossypol, dihydrosterculic acid
and a-tocopherol observed in cotton GHB614 9 LLCotton25 9 MON 15985 when compared to the
non-GM comparator (see Section 3.4.3).
Gossypol is a terpenoid phytoalexin with toxic effects mainly on the male genital system of humans
and animals (EFSA, 2008; OECD, 2009). The EFSA Panel on Contaminants in the Food Chain described
gossypol as undesirable substance in animal feed (EFSA, 2008). Current EU feed legislation has
introduced limits to the maximum content of free gossypol for feed materials and complete feeds.19
These limits are not allowed to be exceeded in order to protect target species and consumers of animal
products derived from animals fed gossypol-containing feed. Direct human consumption of cottonseed
products is predominantly via the reﬁned oil which is essentially free from gossypol (0–0.09% DW total
gossypol, OECD, 2009). An alternative source of consumption of cottonseed products may arise from the
use of ﬂour prepared from seeds. However, the source of such ﬂour is cottonseeds from gland-free
varieties, which do not produce gossypol (EFSA, 2008). Having considered the information on gossypol
toxicity in animals and humans, the effect of processing on the gossypol content of cottonseed feed
materials and the use of certain cottonseed materials as food or feed, the GMO Panel concludes that the
higher content of gossypol in cottonseed of GHB614 9 LLCotton25 9 MON 15985 (both treated and
untreated with the intended herbicides) as compared to the non-GM comparator is of no safety concern
for animals and humans in practice because: (i) the maximum content of free gossypol in feed is
regulated by European legislation19; and (ii) bleached and reﬁned cottonseed oil as well as ﬂour produced
from cottonseed, which may be directly consumed by humans, are essentially free from gossypol.
Dihydrosterculic acid belongs to the category of cyclopropenoid fatty acids (CPFA) described as
antinutrients in cottonseeds (OECD, 2009). CPFA inhibit the desaturation of saturated fatty acids and
have been associated with detrimental effects in animals (OECD, 2009). The minimal increase in the
level of dihydrosterculic acid in cotton GHB614 9 LLCotton25 9 MON 15985 as compared to the non-
GM comparator is considered of no toxicological concern by the GMO Panel.
The toxicity of a-tocopherol has been investigated in animals and in clinical studies, with clotting time
prolongation identiﬁed as the main critical adverse effect (no-observed-adverse-effect-level (NOAEL):
125 mg/kg body weight (bw) per day in the rat). EFSA (EFSA NDA Panel, 2015) set a tolerable upper
intake level (UL) for humans at 300 mg a-tocopherol/day for adults, pregnant and lactating women; and,
for children, 100 mg a-tocopherol equivalent (TE)/day (1–3 years) to 260 mg a-TE/day (15–17 years).
The minimal increase in a-tocopherol observed in cotton GHB614 9 LLCotton25 9 MON 15985 as
compared to the non-GM comparator is considered of no toxicological concern by the GMO Panel.
The GMO Panel concludes that there are no toxicological concerns as regards the changes in the levels
of gossypol, dihydrosterculic acid and a-tocopherol observed in GHB614 9 LLCotton25 9 MON 15985 as
compared to the non-GM comparator.
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3.5.3. Testing of the whole genetically modiﬁed food and feed
No compositional modiﬁcations relevant for safety or nutrition are expected in food and feed
derived from cotton GHB614 9 LLCotton25 9 MON 15985 (Sections 3.4, 3.5.2 and 3.5.5). There was
no indication of interactions relevant for food/feed safety (Sections 3.3 and 3.4). Therefore, animal
feeding studies were not considered necessary (EFSA, 2006a; EFSA GMO Panel, 2011a).
However, a 42-day broiler study27 with animals fed diets including toasted cottonseed meals from
cotton GHB614 9 LLCotton25 9 MON 15985 was provided and evaluated by the GMO Panel.
A total of 420 (210/sex) one-day old chicken broilers (Ross 308) were randomly allocated to three
dietary groups with 140 broilers per treatment (7 pens/treatment per gender, 10 birds/pen) and fed
balanced diets containing up to 10% toasted cottonseed meals from cotton GHB614 9 LLCotton25 9
MON 15985,28 the non-GM comparator (FM958) or a non-GM commercial cotton variety (FM966). Diets
(as crumble pellets or pellets) and water were offered ad libitum. Overall mortality was high
(approximately 10%) with no statistically signiﬁcant difference between the GM group and the two
non-GM groups, in either male or female chickens. During the study, a total of 118 out of 420 birds
(almost 30%) exhibited clinical signs unrelated to treatment. There were no statistically signiﬁcant
differences between treatment groups in male or female body weight by period or total body weight
gain; in weekly mean feed consumption, total mean feed consumption or feed conversion ratio; in
chilled carcass, fat pad, leg, thigh, wing or breast weights. A subset of 126 birds processed for carcass
and tissue weights were also examined for gross pathology at study termination and only four birds29
exhibited abnormal conditions, considered unrelated to treatment.
The GMO Panel is able to draw only limited conclusions from this study, because of the high
mortality and the number of clinical signs observed. However, the measured performance endpoints
were similar in groups fed balanced diets containing 10% of GM and non-GM cottonseed meals.
3.5.4. Allergenicity
For allergenicity assessment, a weight-of-evidence approach is followed, taking into account all
information on the newly expressed proteins as no single piece of information or experimental method
yields sufﬁcient evidence to predict allergenicity (EFSA, 2006a; Codex Alimentarius, 2009; EFSA GMO
Panel, 2011a). In addition, when known functional aspects of the newly expressed protein or structural
similarity to known adjuvants may indicate an adjuvant activity, the possible role of these proteins as
adjuvants is considered. When newly expressed proteins with a potential adjuvant activity are
expressed together, possible interactions increasing adjuvanticity and impacting the allergenicity of the
GM crop are assessed.
3.5.4.1. Assessment of allergenicity of the newly expressed proteins30
The GMO Panel has previously evaluated the safety of the PAT/bar, 2mEPSPS, GUS, NPTII, Cry1Ac
and Cry2Ab2 proteins, and no concerns for allergenicity were identiﬁed (Table 1). No new information
on the allergenicity of these proteins that might change the previous conclusions of the GMO Panel in
the context of the GM events assessed has become available. Based on current knowledge, and as
none of the newly expressed proteins showed allergenicity, no reasons of concern regarding the
simultaneous presence of these newly expressed proteins in the three-event stack cotton affecting
their allergenicity were identiﬁed.
For adjuvanticity, proteins derived from Bacillus thuringiensis (Bt proteins) have been suggested to
possess adjuvant activity, based on animal studies on Cry1Ac when applied at relatively high doses
(e.g. Vazquez et al., 1999). The GMO Panel has previously evaluated the safety of the Cry1Ac and
Cry2Ab2 proteins in the context of applications EFSA-GMO-UK-2008-57 and EFSA-GMO-RX-MON15985
and no concerns on adjuvanticity were identiﬁed (EFSA GMO Panel, 2014a). The levels of Bt proteins
in the three-event stack cotton are similar to those in the respective single events (Section 3.3.2).
From the limited experimental evidence available, the GMO Panel did not ﬁnd indications that the
simultaneous presence of the Bt proteins at the levels expressed in this three-event stack cotton might
act as adjuvants with the potential to enhance a speciﬁc immunoglobulin E (IgE) response and to
favour the development of an allergic reaction.
27 Dossier: Part I – Section D7.8 (study 13798.4125).
28 Sprayed once with glufosinate-ammonium-based herbicides and twice with glyphosate.
29 Two in the non-GM commercial variety group, one in the non-GM comparator group and one in the GM group.
30 Dossier: Part I – Section D7.9; additional information: 3/11/2017.
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From a broader perspective, the effects on the immune system of Cry proteins, in particular Cry1Ac
and Cry1Ab, have been investigated (e.g. Guerrero et al., 2004; Adel-Patient et al., 2011) and the
GMO Panel identiﬁed no indications of safety concern in the context of the applications assessed (EFSA
GMO Panel, 2012, 2016a,b). A recent study by Torres-Martınez et al. (2016) involving the Cry1Ac
protein was assessed by the GMO Panel.31 No reasons for concern were identiﬁed in the context of
this application.
3.5.4.2. Assessment of allergenicity of the whole GM plant32
The GMO Panel regularly reviews the available publications on food allergy to cottonseed-derived
products. However, to date, cotton has not been considered a common allergenic food33 (OECD,
2009). Therefore, the GMO Panel did not request experimental data to analyse the allergen repertoire
of GM cotton.
3.5.4.3. Conclusion
In the context of this application, and considering the data from the molecular characterisation, the
compositional analysis and the assessment of the newly expressed proteins (see Sections 3.3, 3.4.3
and 3.5.2), the GMO Panel found no reasons of concern regarding the allergenicity of food and feed
derived from cotton GHB614 9 LLCotton25 9 MON 15985 with respect to that of food and feed
derived from the non-GM comparator.
3.5.5. Nutritional assessment of GM food/feed
The intended traits of cotton GHB614 9 LLCotton25 9 MON 15985 are herbicide tolerance and
insect resistance, with no intention to alter the nutritional parameters. However, gossypol,
dihydrosterculic acid and a-tocopherol levels were signiﬁcantly different from those in the non-GM
comparator (see Section 3.4). The biological role of these compounds, their levels in cottonseed and
the magnitude and direction of the observed changes were considered during the nutritional
assessment.
3.5.5.1. Human nutrition
Oil is the most important cottonseed-derived product used for human consumption. In Europe, the
consumption of cottonseed oil as such is relatively limited as reﬂected by the lack of consumption data
reported in the EFSA Comprehensive Food Consumption Database (EFSA, 2011). However, cottonseed
oil can also be used as an ingredient in the production of a wide variety of food products such as
dressings, mayonnaise, ﬁne bakery wares, chocolate spreads and chips.
Dihydrosterculic acid (cyclopropaneoctanoic acid, 8-(2-octylcyclopropyl)octanoic acid) is one of a
group of cyclopropane fatty acids (CPA) that together with cyclopropene fatty acids (CPE) occur
infrequently in most plants. Dihydrosterculic acid makes up 0.2–0.4% of total fatty acids in cottonseed
(Xiao-Hong et al., 2011). CPAs are derived from unsaturated fatty acids, e.g. oleic acid, by
cyclopropanation. No information is available about effects in humans. A very small increase (~5%) was
observed in the GM cotton as compared to the non-GM comparator. However, CPAs will be destroyed
during reﬁning and hydrogenation of vegetable oils; therefore, changes in levels of dihydrosterculic acid
31 Torres-Martınez et al. (2016) studied the macrophage activation and the signal transduction pathways by Cry1Ac proteins
using a speciﬁc cell line to elucidate the molecular basis underlying its immunostimulatory mechanisms. The authors concluded
that the Cry1Ac protein tested induced macrophage activation and overproduction of proinﬂammatory cytokines in the speciﬁc
cellular system used. The information collected in this model system was considered as a ﬁrst step which should be further
studied using other cell types of the intestinal mucosa for instance, where relevant exposure to the tested protein could occur.
Additional aspects to investigate included: relevance of the dose, nature of the protein tested (toxin vs protoxin, crystalline vs
soluble), immunisation route and target cells. The authors highlighted the need for investigating such aspects in future studies
to better understand: (i) how Cry1Ac protein is recognised by mammalian cells; and (ii) other signalling pathways that might
be implicated in the effects induced by this protein, including the cytokine proﬁle. The GMO Panel agrees with the authors
that, to elucidate these aspects, additional studies on the immunogenicity of Cry1Ac proteins would be useful. In the context
of the risk assessment of GM plants containing Cry1Ac protein assessed by the GMO Panel, the study by Torres-Martınez et al.
(2016) does not put forward new elements that would invalidate the previous conclusions made by the GMO Panel (EFSA
GMO Panel, 2014a).
32 Dossier: Part I – Section D7.9.
33 Regulation (EU) No 1169/2011 of the European Parliament and of the Council of 25 October 2011 on the provision of food
information to consumers, amending Regulations (EC) No 1924/2006 and (EC) No 1925/2006 of the European Parliament and of
the Council, and repealing Commission Directive 87/250/EEC, Council Directive 90/496/EEC, Commission Directive 1999/10/EC,
Directive 2000/13/EC of the European Parliament and of the Council, Commission Directives 2002/67/EC and 2008/5/EC and
Commission Regulation (EC) No 608/2004.
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in cotton GHB614 9 LLCotton25 9 MON 15985 are considered to be of no concern as regards human
nutrition.
As already commented in the toxicology section (Section 3.5.2), bleached and reﬁned
cottonseed oil does not contain detectable levels of free gossypol; a similar situation occurs for
ﬂours produced from cottonseed. Therefore, the changes in levels of gossypol observed in cotton
GHB614 9 LLCotton25 9 MON 15985 are considered to be of no concern as regards human
nutrition.
a-Tocopherol (vitamin E) is an important micronutrient and antioxidant that prolongs the shelf life of
the oil and food products containing the oil (OECD, 2009). Considering the relatively minor consumption
of cottonseed oil and its negligible contribution to the total intake of vitamin E (EFSA NDA Panel, 2015),
the observed increase of a-tocopherol in cotton GHB614 9 LLCotton25 9 MON 15985 is considered to
be of no concern as regards human nutrition.
3.5.5.2 Animal Nutrition
Cotton can be fed to animals, mainly as cottonseed cake/meal or as full fat cottonseeds especially
in ruminants. Current EU feed legislation has introduced limits to the maximum contents of free
gossypol for feed materials and complete feeds.34 The GMO Panel considers that the changes
observed in the concentration of a-tocopherol (vitamin E) in GHB614 9 LLCotton25 9 MON 15985
cottonseeds are not of concern for animal nutrition, since animal complete feeds are balanced with
vitamins. Based on the current knowledge available on the metabolic activity of dihydrosterculic acid
on animals (Phelps et al., 1965; Page et al., 1997), the minimal increase (~ 5%) observed in
GHB614 9 LLCotton25 9 MON 15985 cottonseeds is not expected to raise health concerns.
3.5.6. Conclusion
In the context of this application, the GMO Panel considers that the newly expressed proteins do not
raise safety concerns for human and animal health in cotton GHB614 9 LLCotton25 9 MON 15985. No
adverse effects for humans and animals resulting from interactions between these proteins are
expected based on their known mode of action. The GMO Panel did not identify safety concerns
regarding allergenicity or adjuvanticity resulting from interactions between the newly expressed proteins
or regarding the overall allergenicity of the three-event stack cotton. The GMO Panel considered that
the compositional differences observed between cotton GHB614 9 LLCotton25 9 MON 15985 and the
non-GM comparator do not raise toxicological concerns. Likewise, the nutritional impact of food and
feed derived from cotton GHB614 9 LLCotton25 9 MON 15985 is not expected to differ from that of
food and feed derived from the non-GM comparator.
3.6. Environmental risk assessment35
Considering the scope of application EFSA-GMO-NL-2011-94, which excludes cultivation, the ERA of
cotton GHB614 9 LLCotton25 9 MON 15985 mainly takes into account: (1) the exposure of bacteria
to recombinant DNA in the gastrointestinal tract of animals fed GM material and bacteria present in
environments exposed to faecal material of these animals (manure and faeces); and (2) the accidental
release into the environment of viable GHB614 9 LLCotton25 9 MON 15985 cottonseeds during
transportation and/or processing (EFSA GMO Panel, 2010).
3.6.1. Persistence and invasiveness of the GM plant36
In southern Europe, Gossypium herbaceum and G. hirsutum have been grown since the 19th
century, and led to transient or locally naturalised cotton plants in the same area (Davis, 1967; Tutin
et al., 1992; Sarno et al., 1993; Celesti-Grapow et al., 2010). However, survival of cottonseeds outside
cultivation areas in Europe is limited due to the absence of a seed dormancy phase. Even if seeds from
spillage germinate, the resulting cotton plants are unlikely to survive because of factors such as cold
climatic conditions, susceptibility to diseases and low competitiveness (Eastick and Hearnden, 2006).
For example, after the end of cotton cultivation in Italy in 1950s, no feral cotton was reported in
southern Italy, except in some restricted areas (Sarno et al., 1993; Celesti-Grapow et al., 2010). Also,
34 Directive 2002/32/EC of the European Parliament and of the Council of 7 May 2002 on undesirable substances in animal feed.
35 Dossier: Part I – Sections D8–10 and Annex 2.
36 Dossier: Part I – Sections D7.1, 7.2, 7.4, 9.1, 9.2 and study 050006.03.
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in other cotton-growing regions such as in Australia, surveys showed that feral GM cotton established
infrequently along transportation routes and mostly as transient populations (Addison et al., 2007).
It is unlikely that the intended traits of cotton GHB614 9 LLCotton25 9 MON 15985 will provide a
selective advantage to cotton plants, except when they are exposed to glyphosate- and/or glufosinate-
ammonium-containing herbicides or infested by insect pests that are susceptible to the Cry1Ac and/or
Cry2Ab2 proteins.
The GMO Panel considers that the ﬁtness advantage provided by the intended traits, and the
observed differences in percentage open bolls, boll size, micronaire, ﬁbre length uniformity, ﬁbre
strength, ﬁbre elongation, number of bolls at ﬁrst position, total number of bolls and parameters
related to lepidopteran susceptibility (see Section 3.4.2) will not allow the GM plant to overcome other
biological and abiotic factors (described above) limiting plant’s persistence and invasiveness. Therefore,
the presence of the intended traits and other observed differences will not affect the persistence and
invasiveness of the GM plant.
In conclusion, the GMO Panel considers that it is very unlikely that cotton GHB614 9
LLCotton25 9 MON 15985 will differ from conventional cotton varieties in its ability to survive until
subsequent seasons, or to establish feral plants under European environmental conditions in case of
accidental release into the environment of viable GHB614 9 LLCotton25 9 MON 15985 cottonseeds.
3.6.2. Effects of gene transfer37
A prerequisite for any gene transfer is the availability of pathways for the transfer of genetic
material, either through HGT of DNA or through vertical gene ﬂow via cross-pollination from feral
plants originating from spilled seeds.
3.6.2.1. Plant-to-microorganism gene transfer
The potential for HGT of the recombinant DNA of the single events has already been assessed in
previous opinions (see Table 1 and EFSA GMO Panel, 2011c). For cotton events GHB614 and
LLCotton25, the GMO Panel concluded that there is no increased likelihood for HGT; for cotton event
MON 15985, the GMO Panel concluded that there is increased likelihood of transfer of the antibiotic
resistance gene nptII, but that MON 15985 material is highly unlikely to contribute to the
environmental prevalence of this gene. No adverse effects on human and animal health and the
environment are expected (EFSA, 2006b, 2009a; EFSA GMO Panel, 2014a). New bioinformatic data38
conﬁrmed the previous conclusions.
Synergistic effects of the recombinant genes, for instance due to combinations of recombinogenic
sequences, which would cause an increase in the likelihood for HGT or a selective advantage were not
identiﬁed.
Therefore, the GMO Panel concludes that the unlikely, but theoretically possible, horizontal transfer
of recombinant genes from this three-event stack cotton to bacteria does not raise any environmental
safety concern.
3.6.2.2. Plant-to-plant gene transfer
The potential for occasional feral cotton GHB614 9 LLCotton25 9 MON 15985 plants originating
from cottonseed import spills to transfer recombinant DNA to sexually compatible plants and the
environmental consequences of this transfer were considered.
For plant-to-plant gene transfer to occur, imported GM cottonseeds need to germinate and develop
into plants in areas containing sympatric wild relatives and/or cultivated cotton with synchronous
ﬂowering and environmental conditions favouring cross-pollination.
Cotton is predominantly an annual self-pollinating crop, although cross-pollination can occur at low
frequencies in the presence of insect pollinators (such as wild bees, honeybees, bumblebees) (OECD,
2008). For cotton, no wild relatives have been reported in Europe; therefore, any vertical gene transfer
is limited to G. hirsutum and G. herbaceum cotton plants. However, gene transfer to G. herbaceum is
considered unlikely due to the difference in ploidy level.
The potential of spilled cottonseeds to establish, grow and produce pollen is extremely low and
transient (see Section 3.6.1). The likelihood/frequency of cross-pollination between occasional feral GM
cotton plants resulting from seed spillage and weedy or cultivated Gossypium plants is considered
37 Dossier: Part I – Section D 9.3.
38 Additional information: 2/2/2018.
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extremely low. Even if cross-pollination would occur, the GMO Panel is of the opinion that the likelihood
of environmental effects as a consequence of the spread of genes from occasional feral GM cotton
plants in Europe will not differ from that of conventional cotton varieties for the reasons given in
Section 3.6.1, even in the case of treatment with the intended herbicides.
3.6.3. Interactions of the GM plant with target organisms39
Taking the scope of application EFSA-GMO-NL-2011-94 into account, potential interactions with the
target organisms of occasional feral cotton GHB614 9 LLCotton25 9 MON 15985 plants arising from
seed import spills are not considered by the GMO Panel to raise any relevant environmental concern.
3.6.4. Interactions of the GM plant with non-target organisms40
Given that environmental exposure of non-target organisms to spilled GM cottonseeds or occasional
feral GM cotton plants arising from spilled GM cottonseeds is limited and because most proteins are
degraded before entering the environment through faecal material of animals fed GM cotton, potential
interactions of the GM plant with non-target organisms are not considered by the GMO Panel to raise
any relevant environmental concern. Interactions that may occur between the Cry proteins (as
mentioned in Section 3.3) will not alter this conclusion.
3.6.5. Interactions with the abiotic environment and biogeochemical cycles41
Considering the scope of application EFSA-GMO-NL-2011-94, and the low level of exposure to the
environment, potential interactions with the abiotic environment and biogeochemical cycles were not
considered a relevant issue by the GMO Panel.
Given that environmental exposure to spilled seeds or occasional feral cotton GHB614 9 LLCotton25 9
MON 15985 plants arising from seed import spills is limited and because most proteins are degraded
before entering the environment through faecal material of animals fed GM cotton, potential interactions
with the abiotic environment and biogeochemical cycles are not considered a relevant issue by the GMO
Panel.
3.6.6. Conclusion
The GMO Panel concludes that it is unlikely that cotton GHB614 9 LLCotton25 9 MON 15985 would
differ from conventional cotton varieties in its ability to persist under European environmental conditions.
Considering the scope of application EFSA-GMO-NL-2011-94, interactions of occasional feral cotton
GHB614 9 LLCotton25 9 MON 15985 plants with the biotic and abiotic environment are not considered
to be relevant issues. The analysis of HGT from cotton GHB614 9 LLCotton25 9 MON 15985 to bacteria
does not indicate a safety concern. Therefore, considering the combined traits and their interactions, the
outcome of the comparative analysis, the routes and levels of exposure, the GMO Panel concludes that
cotton GHB614 9 LLCotton25 9 MON 15985 would not raise safety concerns in the event of accidental
release of viable GM cottonseeds into the environment.
3.7. Post-market monitoring
3.7.1. Post-market monitoring of GM food/feed
No compositional changes relevant for food/feed safety or nutrition were identiﬁed in cotton
GHB614 9 LLCotton25 9 MON 15985 when compared with the non-GM comparator. The GMO
Panel therefore considers cotton GHB614 9 LLCotton25 9 MON 15985 to be as safe as the non-GM
comparator and that post-market monitoring (EFSA, 2006a; EFSA GMO Panel, 2011a) of the food/feed
derived from cotton GHB614 9 LLCotton25 9 MON 15985 is not necessary.
39 Dossier: Part I – Section D9.4.
40 Dossier: Part I – Section D9.5.
41 Dossier: Part I – Section D9.8.
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3.7.2. Post-market environmental monitoring42
The objectives of a PMEM plan, according to Annex VII of Directive 2001/18/EC, are: (1) to conﬁrm
that any assumption regarding the occurrence and impact of potential adverse effects of the GMO, or
its use, in the ERA are correct; and (2) to identify the occurrence of adverse effects of the GMO, or its
use, on human health or the environment that were not anticipated in the ERA.
Monitoring is related to risk management, and thus a ﬁnal adoption of the PMEM plan falls outside
the mandate of EFSA. However, the GMO Panel gives its opinion on the scientiﬁc methodology of the
PMEM plan provided by the applicant (EFSA GMO Panel, 2011b).
As the ERA did not identify potential adverse environmental effects from cotton
GHB614 9 LLCotton25 9 MON 15985, no case-speciﬁc monitoring is required.
The PMEM plan proposed by the applicant for cotton GHB614 9 LLCotton25 9 MON 15985
includes (1) the description of a monitoring approach involving operators (federations involved in
import and processing) reporting to the applicant, via a centralised system, any observed adverse
effect(s) of the GMOs on human health and the environment; (2) a coordinating system established by
EuropaBio for the collection of information recorded by the various operators; and (3) the review of
relevant scientiﬁc publications retrieved from literature searches (Lecoq et al., 2007; Windels et al.,
2008). The applicant proposes to submit a PMEM report on an annual basis and a ﬁnal report at the
end of the authorisation period.
The GMO Panel considers that the scope of the PMEM plan provided by the applicant is consistent
with the intended uses of cotton GHB614 9 LLCotton25 9 MON 15985. The GMO Panel agrees with
the reporting intervals proposed by the applicant in its PMEM plan.
4. Overall conclusions
The GMO Panel was asked to carry out a scientiﬁc assessment of cotton GHB614 9 LLCotton25 9
MON 15985 for import, processing, and food and feed uses in accordance with Regulation (EC)
No 1829/2003.
No new data on the single cotton events GHB614, LLCotton25 and MON 15985 that would lead to
a modiﬁcation of the original conclusions on their safety were identiﬁed. Based on the molecular,
agronomic/phenotypic and compositional characteristics, the combination of cotton events GHB614,
LLCotton25 and MON 15985 in the three-event stack cotton did not give rise to issues regarding food
and feed safety. The newly expressed proteins in the three-event stack cotton did not raise concerns
for human and animal health. Food and feed from cotton GHB614 9 LLCotton25 9 MON 15985 are
expected to have the same nutritional impact as those derived from the non-GM comparator.
The GMO Panel concluded that there is a very low likelihood of environmental effects resulting from
the accidental release of viable seeds from cotton GHB614 9 LLCotton25 9 MON 15985 into the
environment.
No scientiﬁc information that could change the conclusions on this three-event stack was retrieved
in a literature search covering the period since the time of validity of the application.43
The GMO Panel concludes that cotton GHB614 9 LLCotton25 9 MON 15985, as described in this
application, is as safe as the non-GM comparator with respect to potential effects on human and
animal health and the environment.
The GMO Panel considers that post-market monitoring of food/feed derived from cotton
GHB614 9 LLCotton25 9 MON 15985 is not necessary, given that no safety concerns were identiﬁed.
The PMEM plan and reporting intervals are in line with the intended uses of cotton
GHB614 9 LLCotton25 9 MON 15985.
Documentation provided to EFSA
1) Letter from the Competent Authority of the Netherlands received on 18 February 2011
concerning a request for placing on the market of genetically modiﬁed cotton
GHB614 9 LLCotton25 9 MON 15985 submitted by Bayer CropScience in accordance with
Regulation (EC) No 1829/2003 (application reference EFSA-GMO-NL-2011-94).
2) Acknowledgement letter dated 14 March 2011 from EFSA to the Competent Authority of
The Netherlands.
42 Dossier Part I – Section D11 and Annex 3.
43 Additional information: 3/11/2017.
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3) Letter from EFSA to applicant dated 20 April 2011 requesting additional information under
completeness check.
4) Letter from applicant to EFSA received on 31 May 2011 providing a timeline for submission
of responses.
5) Letter from applicant to EFSA received on 27 January 2012 extending the timeline for
submission of responses.
6) Letter from applicant to EFSA received on 2 April 2013 extending the timeline for
submission of responses.
7) Letter from applicant to EFSA received on 3 March 2014 extending the timeline for
submission of responses.
8) Letter from applicant to EFSA received on 16 June 2015 providing additional information
9) Letter from EFSA to applicant dated 15 July 2015 delivering the ‘Statement of Validity’ of
application EFSA-GMO-NL-2011-94 for placing on the market of genetically modiﬁed cotton
GHB614 9 LLCotton25 9 MON 15985 submitted by Bayer CropScience in accordance with
Regulation (EC) No 1829/2003.
10) Letter from EURL-JRC to EFSA dated 16 October 2015 requesting EFSA to stop the clock.
11) Letter from EFSA to applicant dated 24 July 2015 requesting additional information and
stopping the clock.
12) Letter from applicant to EFSA received on 22 October 2015 providing additional
information.
13) Letter EFSA to applicant dated 22 February 2016 re-starting the clock.
14) Letter from EFSA to applicant dated 7 April 2016 requesting additional information and
stopping the clock.
15) Letter from EFSA to applicant dated 12 May 2016 requesting additional information and
maintaining the clock stopped.
16) Letter from applicant to EFSA received on 6 July 2016 providing additional information.
17) Letter from applicant to EFSA received on 16 August 2016 providing additional information.
18) Letter from applicant to EFSA dated 16 August 2016 re-starting the clock.
19) Letter from EFSA to applicant dated 29 September 2016 providing additional information.
20) E-mail from applicant to EFSA received on 9 November 2016 requesting an extension of
deadline for the info requested by EFSA on 29 September 2016.
21) Letter from EFSA to applicant dated 3 November 2017 providing additional information.
22) E-mail from EFSA to applicant dated 11 November 2017 re-starting the clock.
23) Letter from EFSA to applicant dated 11 November 2017 stopping the clock.
24) Letter from applicant to EFSA received on 2 February 2017 providing additional
information.
25) E-mail from EFSA to applicant dated 7 November 2018 re-starting the clock from
2 February 2017.
26) Letter from applicant to EFSA received on 20 February 2018 providing complementary
information.
27) E-mail from EFSA to applicant dated 23 February 2018 re-starting the clock on
20 February 2018.
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Abbreviations
AA amino acid
AAD aminoglycoside adenylyltransferase
ADF acid detergent ﬁbre
ANOVA analysis of variance
bp base pair
bw body weight
CaMV cauliﬂower mosaic virus
CPA cyclopropane fatty acids
CPE cyclopropene fatty acids
CPFA cyclopropenoid fatty acids
Cry crystal protein
DM dry matter
ELISA enzyme-linked immunosorbent assay
EPSPS 5-enolpyruvyl-shikimate-3-phosphate synthase
ERA environmental risk assessment
FA total fatty acids
FM FiberMax
GM genetically modiﬁed
GMO genetically modiﬁed organism
GMO Panel EFSA Panel on Genetically Modiﬁed Organisms
GUS b-D-glucuronidase
HGT horizontal gene transfer
HR homologous recombination
IgE immunoglobulin E
LOD limit of detection
LLOQ lower limit of quantiﬁcation
LOQ limit of quantiﬁcation
NDF neutral detergent ﬁbre
NOAEL no-observed-adverse-effect-level
NPTII neomycin phosphotransferase II
OECD Organisation for Economic Co-operation and Development
ORF open reading frame
PAT phosphinothricin acetyltransferase
PMEM post-market environmental monitoring
TE tocopherol equivalent
UL tolerable upper intake level
UTR untranslated region
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Appendix A – Protein expression data
Table A.1: Means, standard deviation and ranges of protein levels (lg/g dry weight) from cotton
GHB614 9 LLCotton25 9 MON 15985 (treated with glyphosate and glufosinate),
GHB614 (treated with glyphosate), LLCotton25 (treated with glufosinate), and MON
15985 (not treated), from ﬁeld trials performed in USA in 2014(a)
GHB614 3
LLCotton25 3
MON 15985
GHB614 LLCotton25 MON 15985
Cry1Ac
Leaf (4–6 leaf) 32.22(b)  9.85(c)
(21.19–54.12)(d)
31.90  8.38
(15.72–47.80)
Leaf (square initiation) 31.00  15.85
(14.79–64.51)
27.59  8.66
(16.79–45.74)
Leaf (2 weeks after ﬁrst
ﬂower)
25.37  7.20
(14.93–34.45)
22.55  6.35
(16.16–40.31)
Root (square initiation) 4.04  0.64
(< LLOQ–5.01)
5.25  1.64
(< LLOQ–7.84)
Pollen (ﬂowering)(e) 0.21  0.05
(0.15–0.34)
0.18  0.02
(0.14–0.21)
Fuzzy seed (maturity) 11.35  1.13
(9.92–13.22)
10.14  1.50
(7.13–11.96)
Cry2Ab2
GHB614 9
LLCotton25 9
MON 15985
GHB614 LLCotton25 MON 15985
Leaf (4–6 leaf) 167.35  36.91
(121.95–255.62)
139.60  20.86
(103.94–175.15)
Leaf (square initiation) 156.29  32.36
(111.96–203.41)
182.70  20.21
(140.73–218.23)
Leaf (2 weeks after ﬁrst
ﬂower)
180.57  26.88
(140.52–232.73)
189.77  16.09
(164.39–221.56)
Root (square initiation) 78.71  15.84
(47.63–101.15)
84.39  13.06
(62.19–98.64)
Pollen (ﬂowering) 0.90  0.75
< LLOQ–2.88
0.80  0.51
(< LLOQ–2.27)
Fuzzy seed (maturity) 171.21  24.03
(136.07–215.60)
152.77  18.24
(122.26–181.50)
2mEPSPS
GHB614 9
LLCotton25 9
MON 15985
GHB614 LLCotton25 MON 15985
Leaf (4–6 leaf) 279.67  125.83
(104.87–453.86)
303.6678.10
(207.34–470.87)
Leaf (square initiation) 507.11  188.84
(234.08–891.96)
567.24  171.45
(272.34–827.28)
Leaf (2 weeks after ﬁrst
ﬂower)
410.80  42.95
(310.88–495.99)
359.55  79.40
(227.92–478.53)
Root (square initiation) 86.62  27.25
(44.05–127.19)
91.96  21.52
(58.55–125.74)
Pollen (ﬂowering) 11.91  3.03
(6.56–17.48)
13.18  5.90
(7.85–30.01)
Fuzzy seed (maturity) 105.70  12.79
(81.48–127.63)
117.59  12.24
(98.99–133.69)
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PAT
GHB614 9
LLCotton25 9
MON 15985
GHB614 LLCotton25 MON 15985
Leaf (4–6 leaf) 519.38  158.43
(261.28–1029.36)
461.68  49.44
(401.12–608.19)
Leaf (square initiation) 540.34  66.92
(422.13–636.93)
418.55  43.17
(365.42–502.18)
Leaf (2 weeks after ﬁrst
ﬂower)
464.49  43.19
(391.05–543.93)
416.55  57.51
(355.89–539.01)
Root (square initiation) 144.67  43.15
(73.83–194.07)
153.11  20.87
(115.69–183.99)
Pollen (ﬂowering) 1.49  1.06
(0.09–3.81)
0.74  0.66
(0.08–2.24)
Fuzzy seed (maturity) 161.02  19.35
(122.48–193.10)
152.43  19.53
(104.93–172.19)
GUS
GHB614 9
LLCotton25 9
MON 15985
GHB614 LLCotton25 MON 15985
Leaf (4–6 leaf) 180.76  48.27
(112.71–254.48)
205.32  19.53
(162.90–232.64)
Leaf (square initiation) 247.33  35.71
(201.32–294.17)
245.48  38.46
(179.05–308.26)
Leaf (2 weeks after ﬁrst
ﬂower)
174.58  37.33
(119.31–223.39)
147.11  41.61
(87.40–210.30)
Root (square initiation) 65.23  35.17
(18.24–122.00)
58.04  13.88
(33.29–78.46)
Pollen (ﬂowering) 1.56  0.24
(1.17–2.13)
1.42  0.24
(< LLOQ–1.98)
Fuzzy seed (maturity) 32.06  4.20
(21.77–39.52)
29.36  3.35
(20.81–34.06)
NPTII
GHB614 9
LLCotton25 9
MON 15985
GHB614 LLCotton25 MON 15985
Leaf (4–6 leaf) 16.09  2.85
(10.86–22.99)
16.32  1.48
(13.71–18.66)
Leaf (square initiation) 15.24  2.53
(11.35–18.99)
13.79  2.07
(10.65–17.77)
Leaf (2 weeks after ﬁrst
ﬂower)
18.55  1.33
(16.29–20.76)
15.76  1.26
(13.37–17.88)
Root (square initiation) 3.88  0.62
(2.42–4.77)
3.57  0.47
(3.10–4.41)
Pollen (ﬂowering) < LOD
(NA)
< LOD
(NA)
Fuzzy seed (maturity) 6.60  0.91
(5.19–8.34)
6.05  0.62
(4.89–7.52)
Cry: crystal protein; EPSPS: 5-enolpyruvyl-shikimate-3-phosphate synthase; PAT: phosphinothricin acetyltransferase;
GUS: b-D-glucuronidase; NPTII: neomycin phosphotransferase II; LOD: limit of detection; LLOQ: lower limit of quantiﬁcation;
NA: not applicable.
(a): Number of samples is n = 15 except for: Cry1Ac in root (n = 6 and n = 10 of GHB614 9 LLCotton25 9 MON 15985 and
MON 15985, respectively); Cry2Ab2 in pollen (n = 12 of GHB614 9 LLCotton25 9 MON 15985 and MON 15985); GUS in
pollen (n = 14 of MON 15985).
(b): Mean.
(c): Standard deviation.
(d): Range.
(e): Reported values for pollen are derived from fresh weight (FW) tissue.
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